The National Institutes of Health’s Heart, Lung, and Blood Institute has awarded Dr. Christie Ballantyne a $6 million grant to begin research to better understand how mutations contribute to atherosclerotic cardiovascular diseases.
Researchers at Baylor College of Medicine have found that troponin I, a protein that is most commonly used to diagnose heart attack, can be detected with a new high-sensitivity assay in adults without prior cardiovascular disease or heart failure.
We’ve all heard the advice to take a fish oil with omega-3 fatty acids to improve heart health, but are you actually getting the benefits they claim to provide? Dr. Christie Ballantyne says probably not.
Researchers have shown that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy.
Baylor College of Medicine researchers have found that testing a specific type of triglyceride may be a better indicator for predicting risk of cardiovascular disease and stroke compared to traditional risk factors.
Baylor College of Medicine researchers are looking for a means to genetically convert scar tissue into muscle tissue at the cellular level, which could ultimately be a way to treat heart attack and heart failure patients.
As heart month kicks off, doctors at Baylor College of Medicine say the first step to taking control of your health and preventing cardiovascular disease is understanding the basics and what they represent for your heart.
Baylor was selected to join the newly formed Strategically Focused Vascular Disease Research Network of the American Heart Association to focus on understanding the pathobiology underlying the differences in aortic disease between men and women.